Effect of Cuminum cyminum extract, Resvin and Vitamin C in type 2 Diabetic patients

Effect of Cuminum cyminum extract, Resvin and Vitamin C on Antioxidant parameters, Lipids profile , Ghrelin and several biochemical indices in type 2 Diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014100619420N1

Enrollment

160

Registered

2014-11-21

Start date

2014-11-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetics type 2. Non insulin dependent diabetes mellitus

Interventions

Intervention 1: Intervention group: Cumin extract, 15 mg/kg/day, oral, during 60days. Intervention 2: Intervention group: Rezvin, 10mg/kg/day, oral, during 60 days. Intervention 3: Intervention group:

Treatment - Drugs

Placebo

Intervention group: Cumin extract, 15 mg/kg/day, oral, during 60days

Intervention group: Rezvin, 10mg/kg/day, oral, during 60 days

Intervention group: VitC, 500 mg/day, oral, during 60 days

control group: Placebo, one Capsule per day, oral, during 60 days

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: inclusion criteria:Diabetic patient, range of age 30 up to 50 exclusion criteria :smoking, alcoholic patient,have another metabolic or outline disease; use of other drugs or supplements

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total antioxidant capacity. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Ghrelin. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.	—

Secondary

Measure	Time frame
Cholestrol. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glucose. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Triglyceride. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;HDL. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;LDL. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Apo A. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Apo B. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Fe. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Weight. Timepoint: before intervention and 2 month after intervention. Method of measurement: standard scale.;Blood pressure. Timepoint: before intervention and 2 month after intervention. Method of measurement: standard barometer.;HbA1c. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Gamma glutamyl transferase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Paraoxonase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Superoxide dismutase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glutathione peroxidase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Xanthine oxidase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glutathione reductase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glutathione. Timepoint:	—

Measure

Time frame

Cholestrol. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glucose. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Triglyceride. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;HDL. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;LDL. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Apo A. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Apo B. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Fe. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Weight. Timepoint: before intervention and 2 month after intervention. Method of measurement: standard scale.;Blood pressure. Timepoint: before intervention and 2 month after intervention. Method of measurement: standard barometer.;HbA1c. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Gamma glutamyl transferase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Paraoxonase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Superoxide dismutase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glutathione peroxidase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Xanthine oxidase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glutathione reductase. Timepoint: before intervention and 2 month after intervention. Method of measurement: blood analysis.;Glutathione. Timepoint:

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hosein Gharib

Shahrekord University of Medical Science

mohogharib@skums.ac.ir+98 38 1333 0061

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026